Therapeutic efficacy liposome-encapsulated kanamycin Mycobacterium intracellulare infection mice Liposome-encapsulated kanamycin KM therapeutic efficacy experimental infection Mycobacterium intracellulare mice Liposomal KM injections wk reduction degree gross pulmonary lesions growth organisms visceral organs lungs spleen kidneys infected mice free KM free KM mixed empty liposomal vesicles therapeutic effect liposome-encapsulated KM dose dependent doses micrograms KM/mouse/injection Liposome encapsulation tissue distribution KM particular reticuloendothelial organs liver spleen organs accumulation retention liposome-entrapped KM free KM retention liposome-encapsulated KM serum lungs Encapsulation KM liposomal vesicles incorporation drug host peritoneal macrophages antimicrobial activity agent intracellulare macrophages 